STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.
Valeria GerthoferAlexander ScheiterFlorian LükeFelix KeilKirsten UtpatelLaura-Maria-Giovanna PöhmererJohannes SeitzChristoph NiessenAtanas IgnatovWolfgang DietmaierDiego F CalvisiMatthias EvertOlaf OrtmannStephan SeitzPublished in: JCO precision oncology (2021)
Keyphrases